Results 211 to 220 of about 1,854,336 (275)

Targeted DNA Sequencing Reveals Distinct Rare-Variant Profiles in Pulmonary Hypertension Associated with Chronic Lung Diseases. [PDF]

Int J Mol Sci
Bosacoma A, Garcia AR, Madrigal I, Lozano JJ, Sidorova J, Aguilar D, Blanco I, Roger Y, Tura-Ceide O, Sardiné-Rama A, Martín-Ontiyuelo C, Rodríguez-Chiaradía DA, López-Meseguer M, Hernandez-Gonzalez F, Ribas J, Pomares X, Santos S, Molina-Molina M, Fernández-Hernández R, Peinado VI, Barberà JA.   +20 more
europepmc   +1 more source

Clinician and Patient Factors Associated With Long‐Term Glucocorticoid Use in People With Rheumatoid Arthritis Receiving Advanced Therapies

Arthritis Care &Research, EarlyView.
Objective Despite guideline recommendations, long‐term glucocorticoid (GC) use is common in rheumatoid arthritis (RA). We conducted a clinician survey nested within a large registry to identify patient and clinician factors associated with GC use. Methods Clinicians contributing patients to the CorEvitas Rheumatoid Arthritis Registry were surveyed ...
Michael D. George, George Reed, Matthew D. Kearney, Peter F. Cronholm, Kevin Kane, Jeffrey R. Curtis, Dimitrios A. Pappas, Joel M. Kremer   +7 more
wiley   +1 more source

Inflammation Unchecked: Concurrent Kawasaki Disease and Stevens‐Johnson Syndrome in an 18‐Month‐Old Child

Arthritis Care &Research, EarlyView.
Catherine Deffendall, Jodi Backalar, Elizabeth Acevedo Zapata, Adriana Della Porta, Lorin Bibb, Tyler Reese, Charlotte M. Brown   +6 more
wiley   +1 more source

Short‐Term Response to Biologic Therapy in Psoriatic Arthritis Is Not Influenced by Disease Duration at Initiation of Therapy

Arthritis Care &Research, EarlyView.
Objective We aimed to determine whether the short‐term response to biologics in biologic‐naive psoriatic arthritis (PsA) is better in patients initiating biologic treatment early in the disease course. Methods Patients with PsA who started on biologic therapy from the year 2000 to 2025 were included for analysis.
Sung Min Cho, Shangyi Gao, Daniel Pereira, Richard J. Cook, Dafna D. Gladman   +4 more
wiley   +1 more source

Plain language summary of the KRYSTAL-12 study results: adagrasib for non-small cell lung cancer with KRAS^G12C mutations. [PDF]

Future Oncol
Barlesi F, Yao W, Duruisseaux M, Doucet L, Azkárate Martínez A, Gregorc V, Juan-Vidal O, Lu S, De Bondt C, de Marinis F, Linardou H, Kim YC, Jotte R, Felip E, Lo Russo G, Reck M, MichenzIe MF, Yang W, Meade JN, Korytowsky B, Mok TSK, KRYSTAL-12 Investigators.   +21 more
europepmc   +1 more source

Impact of Six‐Month Monitoring Compared to Three‐Month Monitoring of Laboratories During Methotrexate Therapy

Arthritis Care &Research, EarlyView.
Objective To evaluate whether extending the American College of Rheumatology–recommended monitoring interval for complete blood count and liver function tests in patients receiving methotrexate (MTX) affects timely detection of medication‐related toxicity.
Spencer Simko, Ray Zhang, Sohini Mukherjee, Puneet Bajaj, Bonnie L. Bermas   +4 more
wiley   +1 more source

Community Advisory Board Members Speak Out: Insights From an Opioid Overdose Study. [PDF]

Health Expect
Chassler D, Hayes A, McClay C, Macone A, Colón M, Powers K, Alvarez P, Laudate A, Langis G, Tirado T, Battaglia T, Martinez LS.   +11 more
europepmc   +1 more source

Talquetamab for people living with relapsed/ refractory multiple myeloma: plain language summary of the MonumenTAL-1 study. [PDF]

Future Oncol
Chari A, Touzeau C, Berdeja JG, Oriol A, van de Donk NW, Rodríguez-Otero P, Morillo D, Martinez-Chamorro C, Mateos MV, Costa LJ, Caers J, Rasche L, Krishnan A, Ye JC, Karlin L, Lipe B, Masterton T, Tolbert J, Renaud T, Kane C, Heuck C, Moreau P.   +21 more
europepmc   +1 more source

Partnering with patients and the public in the clinical trials ecosystem: a decade of lessons learned and shared. [PDF]

BMJ Open
Richards DP, Fink C, Granieri M, Kobow K, Lane T, Lillie D, Mitchell K, Munro C, Smith M, Walz M, Marlin S.   +10 more
europepmc   +1 more source

Authentic participatory research with older adults for cognitive health (APROACH) in rural Botswana and urban Montreal: protocol for a pilot randomised controlled trial. [PDF]

BMJ Open
Andersson N, Cockcroft A, Wilchesky M, Sarmiento I, Batisi O, Chakravarty M, Geddes M, Grimard F, Hachinski V, Mitchell C, Pichora-Fuller K, Abbasgholizadeh Rahimi S, Sawchuk K, Wittich W, Thabane L.   +14 more
europepmc   +1 more source